Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Shengyan, Xi"'
Autor:
Wei Zhuang, Shaoli Liu, Xusheng Zhao, Nan Sun, Tao He, Yali Wang, Beibei Jia, Xiaolan Lin, Yanqi Chu, Shengyan Xi
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Warfarin is a commonly used oral anticoagulant. It has a narrow therapeutic window and wide variation in individualized dosing, and is used clinically for the treatment of thromboembolic diseases. Due to the widespread use of traditional
Externí odkaz:
https://doaj.org/article/33efe2ebd29847bd9f67b1dcbe55e6ad
Autor:
Shengyan Xi, Xiangyang Zhai, Yanan Wang, Yuewen Gong, Biqian Fu, Chunling Gao, Xuehui Guo, Yunhong Li, Zheng Wang, Shuqiong Huang, Dawei Lu, Yufang Zhao, Linchao Qian, Yanhui Wang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Ciji-Hua’ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medicine formula, which specifically targets different aspects of chemotherapy-induced adverse effects in patients with cancer. In our clinical application, CHB-II-F si
Externí odkaz:
https://doaj.org/article/39735229defb45a08dfa24fe313cb303
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Viral pneumonia is one kind of acute respiratory tract infection caused by the virus. There have been many outbreaks of viral pneumonia with high contagiousness and mortality both in China and abroad, such as the great influenza in 1918, the severe a
Externí odkaz:
https://doaj.org/article/f9f48eb324ed49a5a213a0b640af70d7
Autor:
Wei Zhuang, Zheng Fan, Yanqi Chu, Haizheng Wang, Ying Yang, Li Wu, Nan Sun, Ge Sun, Yuqiao Shen, Xiaolan Lin, Guiming Guo, Shengyan Xi
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundCoronavirus Disease 2019 (COVID-19) is an emerging and rapidly evolving disease, with no recommended effective anti-coronavirus drug treatment. Traditional Chinese Patent Medicines (CPMs) have, however, been widely used to treat COVID-19 in
Externí odkaz:
https://doaj.org/article/2801f06a96db4fbfb8c57d2c704fc7a2
Autor:
Xinyue, Zhao, Shengyan, Xi, Yanhui, Wang, Yangxinzi, Xu, Galia, Pollock, Yu, Su, Yao, Cheng, Guanjie, Loy, Pei, Liu
Publikováno v:
In Journal of Traditional Chinese Medicine 15 February 2017 37(1):88-95
Autor:
Axiang Peng, Yuehong Gao, Xiaomei Zhuang, Yaoqi Lin, Wencan He, Yannan Wang, Wenfan Chen, Tingting Chen, Xiaoqing Huang, Renzhi Yang, Yuanpeng Huang, Shengyan Xi, Xian Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Alzheimer’s disease (AD) is the most common neurodegenerative disorder associated with aging. There are currently no effective treatments for AD. Bazhu decoction (BZD), a traditional Chinese medicine (TCM) formula, has been employed clinically to a
Externí odkaz:
https://doaj.org/article/c08d882356a94e79b37356e20b7bbb18
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Gestational diabetes mellitus is the most common metabolic disorder during pregnancy with health consequences for both lives during and after pregnancy. Studies found that many pregnant women turn to complementary and alternative medicine for health
Externí odkaz:
https://doaj.org/article/a40ec4f88d714f8c8f4a9204ba4cb7b5
Autor:
Biqian Fu, Shengyan Xi, Yanhui Wang, Xiangyang Zhai, Yanan Wang, Yuewen Gong, Yangxinzi Xu, Jiaqi Yang, Yingkun Qiu, Jing Wang, Dawei Lu, Shuqiong Huang
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2019)
Ciji-Hua’ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechani
Externí odkaz:
https://doaj.org/article/3fe77e8aa7c64e38ab0155edfc6fab2e
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Glioblastoma is the most common type of brain tumor and is invariably fatal, with a mean survival time of 8-15 mo for recently diagnosed tumors, and a 5-year survival rate of only 7.2%. The standard treatment for newly diagnosed glioblasto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07230eb05f804a81338a4e4a31f84034
http://europepmc.org/articles/PMC8058673
http://europepmc.org/articles/PMC8058673
Autor:
Xiaoqing Huang, Qiongyun Chen, Yanyun Fan, Renzhi Yang, Guoyu Gong, Changsheng Yan, Yang Song, Bangzhou Zhang, Shengyan Xi, Yuanpeng Huang, Hongzhi Xu
Publikováno v:
Biomedicine & Pharmacotherapy. 159:114300
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72fd275a3bd7b044bd03a1cb9f720041
https://doi.org/10.1016/j.biopha.2023.114300
https://doi.org/10.1016/j.biopha.2023.114300